List of works by Daniel Stadlbauer

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

scientific article published on 07 December 2020

A serological assay to detect SARS-CoV-2 seroconversion in humans

scientific article published on 18 March 2020

A serological assay to detect SARS-CoV-2 seroconversion in humans

scientific article published on 12 May 2020

Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans

scientific article published on 13 July 2020

Anti-SARS-CoV-2 Spike Antibodies are Stable in Convalescent Plasma when Stored at 4° Celsius for at Least 6 Weeks

scientific article published on 14 August 2020

Antibody responses to influenza A(H1N1)pdm infection

scientific article published on 07 May 2020

Broadly protective human antibodies that target the active site of influenza virus neuraminidase

scientific article published on 01 October 2019

Characterization of swine-origin H1N1 canine influenza viruses

scientific article published on 01 January 2019

Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice

article

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

scientific article published on 15 September 2020

Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.

scientific article published on 20 June 2018

Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs

article

Novel correlates of protection against pandemic H1N1 influenza A virus infection

scientific article published on 03 June 2019

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts

scientific article published on 06 December 2019

Pre-existing anti-neuraminidase antibodies are associated with shortened duration of influenza A (H1N1)pdm virus shedding and illness in naturally infected adults

scientific article published on 12 July 2019

Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City

scientific article published on 03 November 2020

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

scientific article published on 28 October 2020

SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

scientific article published on 01 June 2020

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model

scientific article published on 10 April 2019

Universal influenza virus vaccines: what can we learn from the human immune response following exposure to H7 subtype viruses?

scientific article published on 20 November 2017

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge

scientific article published on 21 August 2019

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans

scientific article published in November 2017